Back to User profile » Dr Junying Xu
Papers published by Dr Junying Xu:
PSMC2 is a Novel Prognostic Biomarker and Predicts Immunotherapeutic Responses: From Pancreatic Cancer to Pan-Cancer
Huang W, Qian Z, Shi Y, Zhang Z, Hou R, Mei J, Xu J, Ding J
Pharmacogenomics and Personalized Medicine 2023, 16:747-758
Published Date: 9 August 2023
Total T Cell Density and Expression of T Memory Stem Cell Markers are Associated with Better Prognosis in Colon Cancer
Ding J, Wang H, Hou R, Shi Y, Fan H, Li Y, Mei J, Zhang Q, Ruan T, Xu J
International Journal of General Medicine 2023, 16:2285-2294
Published Date: 5 June 2023
GBP5 Identifies Immuno-Hot Tumors and Predicts the Therapeutic Response to Immunotherapy in NSCLC
Fan H, Shi Y, Wang H, Li Y, Mei J, Xu J, Liu C
International Journal of General Medicine 2023, 16:1757-1769
Published Date: 10 May 2023
The Clinical Significance of Deglycosylated PD-L1 Level Detection Using 28-8 Monoclonal Antibody in Lung Adenocarcinoma
Wang H, Gu D, Chen D, Mei J, Yang X, Ding J, Xu J, Wang M, Liu C, Hua D
International Journal of General Medicine 2022, 15:7383-7393
Published Date: 19 September 2022